信号转导通路,Signal transduction pathway
1)Signal transduction pathway信号转导通路
1.Analysis of signal transduction pathways involved in spontaneous reversibility of hepatic fibrosis;肝纤维化自发逆转的相关信号转导通路研究
2.Progress of signal transduction pathway of gastrin stimulating proliferation of colorectal carcinoma cells;胃泌素促进大肠癌细胞增殖信号转导通路的研究进展
3.MicroRNAs and cancer-associated signal transduction pathways;MicroRNA与肿瘤相关的信号转导通路
英文短句/例句
1.Translation Control Regulated by TOR Signaling PathwayTOR信号转导通路介导的翻译控制
2.The Relationship between the Hepatitis B Virus X Protein and β-Catenin;HBX对Wnt/β-catenin信号转导通路的影响研究
3.Signal transduction pathways in exercise induced cardiac myocyte hypertrophy(A review);运动性心肌肥大的信号转导通路(综述)
4.Notch signaling pathway and primary liver cancerNotch信号转导通路与原发性肝癌
5.PTEN signaling pathways and multidrug resistance of tumorPTEN信号转导通路与肿瘤的多药耐药
6.Glutamine synthetase and Wnt-signaling谷氨酰胺合成酶与Wnt信号转导通路
7.Dynamic modeling of cell apoptosis signaling pathway细胞凋亡信号转导通路的动力学模拟
8.STAT3 Signal Transduction Pathway and Methods for Tumor TherapySTAT3信号转导通路及肿瘤治疗的方法
9.NF-κB signal transduction pathway and insulin resistanceNF-κB信号转导通路与胰岛素抵抗
10.Study on Cell Signaling Pathways during Ultraviolet Irradiation-Induced Apoptosis;辐射诱导的细胞凋亡信号转导通路研究
11.Roles of Reactive Oxygen Species in MAPKs of Cells Exposed to Selenite;硒诱导产生ROS在MAPKs信号转导通路中的调节作用
12.Signal Transduction Pathways Mediated by Growth Factor Receptor;生长因子受体介导的信号转导通路研究进展
13.Quantitatively Imaging Induced Activation of Rac1, Cdc42 Signaling Pathways定量成像诱导激活的Rac1、Cdc42信号转导通路
14.Role of PI3K in Platelet-derived Growth Factor and Fibronectin Induced Proliferation of Human Fibroblast CellsPDGF、FN诱导FHL1细胞增殖的PI3K信号转导通路研究
15.Study on the Regulation Effect of Angelica Polysaccharides on the Signal Transduction Pathway Mediated by EpoR in K562 Cells当归多糖对K562细胞EpoR介导的信号转导通路研究
16.The Correlation between the Tiam1-Rac1-PAK1 Sigual Transduction Pathway and the Invasion and Metastasis of Colorectal Carcinoma;Tiam1-Rac1-PAK1信号转导通路与大肠癌侵袭转移的关系
17.CORRELATION OF NFKB SIGNAL PATHWAY WITH TUMOR METASTASIS OF HUMAN ORAL SQUAMOUS CELL CARCINOMANF-κB信号转导通路与口腔鳞癌转移关系的研究
18.Apoptosis of U937 cell line promoted by matrine through MAPK signal transduction pathway苦参碱通过MAPK信号转导通路促进U937细胞凋亡
相关短句/例句
signaling pathway信号转导通路
1.AIM: To explore the possible mechanism of action of Wnt/β-cateninsignaling pathway in hepatocarcinogenesis by investigating the different expressions of the main members on thissignaling pathway in hepatocellular carcinoma cell line HepG2 and L02 cell line.目的:比较Wnt/β-catenin信号分子在HepG2和L02细胞中的表达,探讨Wnt/β-catenin信号转导通路在肝癌发生中的作用机制,为肝癌的防治提供新的思路。
2.TLR4-mediated MyD88(myeloid differentiation protein 88 )signaling pathway pTLR4(Toll-like receptor 4,TLR4)是一种模式识别受体(patternrecognition receptor,PRRs),能识别病原体,在病原体入侵机体的早期启动固有免疫,TLR4介导的髓样分化蛋白MyD88(myeloid differentiation protein 88,MyD88)信号转导通路在抗感染中发挥重要作用。
3)Signaling transduction pathway信号转导通路
1.AIM: To investigate the role of Wnt/β-catenin signaling transduction pathway in rat hepatocarcinogenesis.目的:探讨Wnt/β-catenin信号转导通路与肿瘤发生的关系,为肝癌的防治提供新的思路。
2.AIM To investigate the expressions of associated proteins of signaling transduction pathway in hippocampal nerve system of KKAy mouse with type 2 diabetes.结论 2型糖尿病KKAy小鼠存在海马胰岛素信号转导通路的异常 ,主要表现为Ras途径和PI3 K两条途径的异常。
4)Signal transduction信号转导通路
1.Akt is thought to be a key mediator of signal transduction processes,it plays important roles in regulating cell survival,growth,proliferation,function and nutrient metabolism in heart in response to growth factors and other extracellular stimuli.关键词:Akt,心肌保护,信号转导通
5)Signal pathway信号转导通路
1.Gene expression of Smad signal pathway in adrenal gland in H22 tumor-bearing mice with different syndromesSmad信号转导通路在不同证候H22荷瘤小鼠肾上腺的基因表达
6)RISK pathwayRISK信号转导通路
1.RISK pathway and cardiac protection of renal ischemic postconditioning;RISK信号转导通路与肾缺血后处理的心肌保护作用
延伸阅读
脉心导敏 ,脉导敏,英他佐明,麦新导明药物名称：吗多明英文名：Molsidomine别名： 吗导敏;吗多明;吗斯酮胺;脉心导敏 ,脉导敏,英他佐明,麦新导明外文名：Molsidomine 特点： 脉导敏是一种属于亚胺类化合物，其作用与硝酸盐相似。舌下含服1毫克，2～4分钟起作用，可阻止心绞痛发作。口服一次可持续6～7小时，剂量每天3次，每次2毫克。副作用包括头痛、头胀、脸部发热感等，但不多见。 适应症： 防治心绞痛的发作。 用量用法： 口服：１次１～２ｍｇ，１日２～３次，发作时舌下含服：１次２ｍｇ。喷雾吸入：每次揿吸１～２次（相当于本品０．２～０．４ｍｇ），每日次数酌定。 注意事项： 1.一般不良反应可有头痛、面部潮红、眩晕等，停药后可自行消失。 2.低血压、青光眼病人忌用。 规格： 片剂：每片１ｍｇ、２ｍｇ。 气雾剂：每瓶含４２ｍｇ（可揿吸２００次左右）。 类别：非选择性钙通道阻滞剂||防治心绞痛药
